Hepion Pharmaceuticals Inc (HEPA)
0.661
-0.03
(-4.20%)
USD |
NASDAQ |
Sep 27, 16:00
0.661
0.00 (0.00%)
After-Hours: 19:48
Hepion Pharmaceuticals Cash from Financing (Quarterly): 0.00 for June 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.00 |
| March 31, 2024 | 1.850M |
| December 31, 2023 | 4.495M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | -3.138M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | -2.00M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | -0.1766M |
| March 31, 2021 | 82.15M |
| December 31, 2020 | 31.62M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 4.637M |
| March 31, 2020 | 6.800M |
| December 31, 2019 | 1.505M |
| September 30, 2019 | -0.4822M |
| June 30, 2019 | 16.74M |
| March 31, 2019 | 0.9465M |
| Date | Value |
|---|---|
| December 31, 2018 | -1.107M |
| September 30, 2018 | 9.996M |
| June 30, 2018 | 2.00M |
| March 31, 2018 | 1.635M |
| September 30, 2017 | 1.169M |
| June 30, 2017 | 11.10M |
| March 31, 2017 | 0.7907M |
| December 31, 2016 | 12.88M |
| September 30, 2016 | 0.0022M |
| June 30, 2016 | 6.338M |
| March 31, 2016 | 0.0007M |
| December 31, 2015 | 13.53M |
| September 30, 2015 | 0.0334M |
| June 30, 2015 | 0.0012M |
| March 31, 2015 | 3.00M |
| December 31, 2014 | 9.50M |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 2.86M |
| December 31, 2013 | 0.15M |
| September 30, 2013 | 0.10M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-3.138M
Minimum
Dec 2022
82.15M
Maximum
Mar 2021
6.363M
Average
--
Median
Sep 2020
Cash from Financing (Quarterly) Benchmarks
| MEI Pharma Inc | -0.208M |
| Mira Pharmaceuticals Inc | 0.159M |
| NovaBay Pharmaceuticals Inc | -0.492M |
| Palatin Technologies Inc | 9.136M |
| iBio Inc | 12.99M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -10.93M |
| Free Cash Flow | -34.78M |
| Free Cash Flow Per Share (Quarterly) | -1.884 |
| Free Cash Flow Yield | -1.10K% |